NewMarket Corporation (NYSE: NEU) — A Mature Moat Priced Like a Growth Engine

Report date: 2026-08-27 Market data through: 2026-08-26 Reference price: $925.33 Currency: U.S. dollars; financial figures in millions unless stated otherwise Scope: Fresh coverage based on the trailing five-year SEC filing corpus, the latest reported quarter, public industry evidence, and filing-reconciled financial analysis.

The analysis in Sections 1–15 is position-free and contains no recommendation or price target. Facts, interpretations, assumptions, and open questions are identified where the distinction matters. Management statements are treated as hypotheses until corroborated by filings, operating results, or external evidence.

⚡ Claude’s Take

The author’s own subjective opinion; general information only, not investment advice. The analytical body in Sections 1–15 below carries no position.

HOLD / avoid chasing at $925; not a short. Accumulate aggressively at or below about $700, selectively at $700–$775, hold at $775–$950, and avoid new capital or trim above $950–$1,000 unless Specialty Materials demonstrates more than $100 million of sustainable EBITDA and Afton holds a 20% or better margin without temporary surcharges.

NewMarket owns a real franchise. Afton sells a qualified performance outcome rather than a commodity molecule, and the same four global lubricant-package suppliers have remained in place for roughly two decades. That customer captivity plus technical scale has produced recovered petroleum-additive margins above 20%, strong five-year cash conversion, and genuine share-count shrink. The problem is not quality; it is the amount of quality already capitalized. At $925.33, live enterprise value is $9.27 billion, or 13.7 times trailing EBITDA and 16.9 times trailing EBIT, while price-to-sales sits at the 99.5th percentile of NEU’s own history. A reasonable base case in which Afton keeps a 20% margin and Specialty Materials compounds still generates only about 2.5% annualized five-year total return from this entry point.

The framing is a quality compounder at a full price with event-driven momentum. The shares are 23.8% above their 200-day exponential average, up 51.4% in six months and only 5.8% below the August record. Yet factor models explain just 19.8% of return variance, specific volatility is about 30.9%, and the five-year maximum drawdown is 32.8%. Low beta is not low risk here; earnings expectations, a small float, and confidence in peak-like margins drive the tape. The current quote nearly equals the generous segment valuation case and asks investors to underwrite both mature-franchise economics and an unproven roughly $1 billion defense-and-space capital program.

Conviction: medium. The evidence that would flip this view bullish is disclosed organic Specialty Materials growth and returns sufficient to sustain more than $120 million of EBITDA without higher leverage. The bearish flip is petroleum operating profit below roughly $450 million with persistent qualified-volume loss while the stock still carries a premium multiple. The moat is mature; the valuation assumes the growth engine is already running.

📈 Stock Price Action — Five-Year Event Map

NEU’s adjusted price rose from a five-year low near $259 in September 2022 to a record near $982 on 2026-08-17 and closed at $925.33 on 2026-08-26. Its trailing 52-week adjusted range was approximately $575–$982, leaving the current price about 5.8% below the peak after a 197.1% five-year total return. That path still included a 32.8% maximum drawdown and repeated earnings-day moves near 10%. AZI NEU adjusted daily-history CSV, pulled 2026-08-27.

Events 1 and 2 correspond to the input-cost squeeze documented in the FY2021 and FY2022 filings: petroleum margins fell to 12.0% in 2021 and recovered only to 13.7% in 2022. Events 3 and 4 mark the delayed pass-through recovery that ultimately carried the margin to 22.5% in 2024. NewMarket FY2022 Form 10-K, filed 2023-02-15, Q1 2023 Form 10-Q, filed 2023-04-27, Q3 2023 Form 10-Q, filed 2023-10-26, and NewMarket FY2025 Form 10-K, filed 2026-02-12, accessed 2026-08-27.

Events 5 through 7 show that the new valuation regime remains earnings-sensitive. The 2026 selloff followed a 12.1% decline in FY2025 petroleum segment profit; the July rebound followed a quarter in which $29.6 million of petroleum price/mix, including Middle East surcharges, more than offset a $10.1 million shipment drag. Same-day earnings attribution is strong; non-earnings price moves remain probabilistic. NewMarket Q1 2024 Form 10-Q, filed 2024-04-25 and Q2 2026 Form 10-Q, filed 2026-07-30, accessed 2026-08-27.

1. Executive Summary

NewMarket is best understood as two capital cycles inside one holding company. Afton Chemical, the Petroleum Additives segment, is a mature, slow-growth oligopoly franchise. It supplies lubricant and fuel additive packages whose economic value lies in formulation, testing, qualification, and reliable global delivery. AMPAC and Calca, the Specialty Materials segment assembled through acquisitions in 2024 and 2025, make mission-critical ammonium perchlorate and high-purity hydrazine for defense and space propulsion. Their qualification barriers may be stronger than Afton’s, but their financial record under NewMarket is short and their growth is acquisition- and capacity-driven.

Fact — the franchise is visible in the numbers. Petroleum Additives produced $2,533.6 million of FY2025 sales and $520.1 million of segment operating profit, a 20.5% margin. The same segment earned margins of 19.1% in 2023 and 22.5% in 2024 after troughing at 12.0% in 2021 and 13.7% in 2022. In H1 2026, shipments fell 5.3%, partly because management says it pruned low-margin business, while segment profit increased to $284.4 million and margin rose to 22.1%. The evidence supports real but lagged pricing power: qualification friction eventually permits cost recovery, but it does not eliminate raw-material, volume, plant, or logistics risk. NewMarket FY2025 Form 10-K and Q2 2026 Form 10-Q, accessed 2026-08-27.

Interpretation — the moat is durable but shared. NewMarket described itself as one of four large lubricant-additive suppliers and named Lubrizol, Infineum, and Chevron Oronite as the other major players in both 2015 and 2025. Customers do not switch casually because an additive package is embedded in a base-oil formulation, test history, API or OEM claim, production process, and warranty risk. Afton then spreads about $132 million of annual R&D/testing and a global technical network over a large installed revenue base. In Greenwald’s taxonomy, customer captivity plus economies of scale is the defensible mechanism. Patents and chemical know-how support it but are not independently permanent; there is no network effect. Exact current shares are unavailable, so the preferred market-share-stability test cannot be completed.

Fact — earnings quality is strong over a cycle, but reported EPS needs adjustment. FY2021–25 cumulative cash from operations was $1,939.3 million versus $1,740.5 million of net income. After $318.4 million of capex, cumulative free cash flow was $1,621.0 million, or 93% of net income. Annual conversion ranged from 19% to 136% because inventory built during the 2021–22 shock and released in 2023. FY2025 non-service pension/postretirement income of about $53 million, however, was 9.5% of pretax income. The related $605.4 million June 2026 prepaid pension asset is real, but operating profit and cash flow are cleaner operating anchors than unadjusted EPS. NewMarket FY2025 Form 10-K and Q2 2026 Form 10-Q, accessed 2026-08-27.

Interpretation — legacy capital allocation was unusually good; the new pivot is unresolved. Shares outstanding fell 15.8% from December 2020 to June 2026, and stock compensation is immaterial. Repurchases were largest when the shares were cheaper in 2021–22 and slowed as price rose. Dividends per share compounded 8.9% from 2021 through 2025. NewMarket also repaired acquisition debt quickly: June 2026 net debt was $761.2 million and bank leverage was 1.20 times against a 3.75 times covenant. The burden of proof now rests on roughly $1 billion committed to AMPAC, Calca, and their capacity. Acquisition accounting assigned most consideration to goodwill and intangibles; management discloses no stand-alone Calca economics, synergy target, or return hurdle.

Fact — valuation recognizes the moat and pre-capitalizes much of the new growth. At $925.33 and 9.196 million basic shares, equity value is $8.51 billion. Adding $761.2 million of net debt produces $9.27 billion of live enterprise value: 3.38 times trailing sales, 13.71 times EBITDA, and 16.93 times EBIT. Current EV/EBITDA is above the 2014–25 75th percentile of date-matched annual observations, while P/S is at the 99.5th percentile of NEU’s own available history. A central segment valuation yields about $814 per share and a generous case about $934; a five-year base case generates about 2.5% annualized total return from the reference price. These are assumption-driven valuation diagnostics, not targets.

The thesis therefore turns on four questions. First, are 20% or better Afton margins a sustainable product of industry structure or a cyclical high helped by surcharges? Second, is lower volume deliberate value-over-volume discipline or early share loss and petroleum-fluid attrition? Third, can Specialty Materials earn an attractive return on acquired and expansion capital after commissioning? Fourth, will governance and incentives enforce returns when the family-controlled board has no ROIC or free-cash-flow metric in executive pay? The evidence answers the first question positively but not permanently; the remaining three require future disclosure and operating proof.

Verdict: NewMarket is a high-quality, cash-generative franchise with a genuine qualification-and-scale moat. Its core growth is low, its new growth is purchased and not yet return-proven, and its current valuation embeds a favorable answer to questions the filings cannot yet settle.

2. Business Overview and Economic Model

NewMarket is a holding company with two reportable businesses. Petroleum Additives consists mainly of Afton Chemical’s lubricant and fuel-additive packages, plus Ethyl’s antiknock compounds and contracted manufacturing. Specialty Materials consists of American Pacific Corporation, or AMPAC, acquired on 2024-01-16, and Calca Solutions, acquired on 2025-10-01. AMPAC makes ammonium perchlorate and related materials used in solid rocket motors; Calca makes high-purity and Ultra Pure hydrazine used in spacecraft propulsion. NewMarket FY2025 Form 10-K, filed 2026-02-12, accessed 2026-08-27.

Petroleum Additives: a qualified outcome, not a molecule

Afton makes chemical components, blends them into additive packages, and sells mainly to integrated oil companies and independent lubricant compounders or blenders. Those customers combine the package with base oils and sell the finished lubricant. The package supplies detergency, dispersion, oxidation control, wear protection, viscosity behavior, friction performance, deposit control, and other properties needed to meet industry or OEM claims. Fuel additives serve refiners, terminals, marketers, and blenders seeking deposit control, cleanliness, combustion, refinery-process, or emissions performance.

The commercial logic is asymmetric. Additives are only a portion of the finished fluid’s cost but influence the performance of an engine, transmission, turbine, or industrial asset worth orders of magnitude more. A failed or off-spec formulation can create warranty costs, equipment damage, brand harm, or a requalification cycle. A customer therefore buys a tested performance envelope, technical support, and supply reliability rather than the cheapest kilogram of chemistry. That explains why a formulation supplier can possess pricing power even though many individual raw materials are commodity-like.

API’s current licensing framework makes the mechanism tangible. ILSAC GF-7A and GF-7B became effective on 2025-03-31, with licensed oils required to meet specified engine, bench, chemical, and physical tests; OEMs may impose additional requirements. Afton employed about 450 people in R&D and testing at year-end 2025, spent $132.1 million on petroleum-additive R&D, and held roughly 1,400 issued or pending patents. API 1509, 23rd edition, accessed 2026-08-27; NewMarket FY2025 Form 10-K, accessed 2026-08-27.

Lubricant additives were 85% of petroleum-additive sales in 2025. Segment sales of $2.534 billion included $2.156 billion of lubricant additives and $378 million of fuel additives. Engine oils represent about 70% of industry lubricant-additive volume; driveline and industrial applications represent the balance. The high engine-oil exposure creates a long-duration volume challenge from drain-interval extension and electrification, but hybrids, commercial fleets, off-road equipment, industrial uses, and a slowly turning installed fleet delay the transition.

Specialty Materials: narrow, mission-critical qualification

AMPAC’s ammonium perchlorate is the oxidizer in solid rocket motors. Customers include U.S. defense and space programs, allied programs, and commercial-space participants. The job to be done is consistent, safely handled material with controlled particle characteristics produced at a qualified site. NewMarket states that most foreign capacity is not qualified for the majority of U.S. government and NASA programs. Calca’s high-purity hydrazine is used for orbit insertion, station-keeping, attitude control, and deorbit. Purity, process consistency, handling, audit history, regulatory compliance, and mission heritage matter because failure can mean mission loss. NewMarket FY2025 Form 10-K, accessed 2026-08-27.

This is potentially stronger captivity than in ordinary lubricant formulations, but it is narrower. Program budgets and launch schedules can make quarterly demand uneven. AMPAC and Calca each carry meaningful single-site exposure, and government qualification can reflect procurement policy as well as intrinsic production advantage. Moreover, NewMarket bought these positions rather than building them organically. The acquisition price and follow-on capacity therefore belong in any return analysis.

Specialty Materials generated $182.5 million of FY2025 sales and $47.0 million of segment operating profit, a 25.8% reported margin. The figure is not a normalized run rate: FY2025 includes a full year of AMPAC, only three months of Calca, acquisition amortization, and program mix. H1 2026 sales increased to $125.3 million from $95.8 million, while operating profit rose only to $34.8 million from $33.7 million. Q2 alone was much stronger, at $67.2 million of sales and $22.3 million of operating profit. Acquisition timing and quarterly mix make the short period unsuitable for extrapolation. NewMarket Q2 2026 Form 10-Q, accessed 2026-08-27.

Revenue recurrence and customer economics

NewMarket does not have contractual recurring revenue in the software sense. Demand repeats because customers continuously manufacture lubricants, fuels, rocket motors, and spacecraft, while qualified formulations and processes tend to persist. Revenue is recognized at a point in time and normal payment terms generally do not exceed one year. Rebate-estimate true-ups were only $3 million in 2025, $4 million in 2024, and $5 million in 2023, suggesting little revenue-estimation noise. NewMarket FY2025 Form 10-K, accessed 2026-08-27.

No individual customer represented 10% or more of consolidated sales in 2023–25. That does not mean buyer power is absent: the filing also describes reliance on a small number of significant petroleum-additive customers, primarily multinational oil companies. A customer below the reporting threshold can still move a meaningful formulation program, and Infineum and Oronite are vertically connected to ExxonMobil/Shell and Chevron, respectively. Afton’s independence may make it a neutral partner to other marketers, but it lacks captive parent demand.

Verdict: The business model is understandable and attractive. Afton monetizes qualification, test data, technical scale, and supply assurance; Specialty Materials monetizes even narrower program and process qualification. The recurring economic relationship is real, but revenue is volume- and program-driven rather than contractually recurring, and buyer power prevents treating captivity as absolute.

3. Industry Structure and Capital Cycle

Value chain and location of the profit pool

The lubricant value chain starts with base oils and petrochemical intermediates, moves through functional components such as detergents, dispersants, antioxidants, antiwear agents, viscosity modifiers, and friction modifiers, then through package formulators, lubricant marketers, and OEM or service channels. Upstream inputs are often commodity-like and cyclical. The more defensible profit pool sits with full-package formulators that combine components, own performance data, manage qualification, and provide global technical and supply support.

Evonik estimates that a typical lubricant contains 70%–90% base fluid, 5%–15% detergent-inhibitor additive package, and 0.5%–10% viscosity modifier. That modest package content relative to the protected asset strengthens the value proposition: customers have little reason to risk a high-cost failure for a small formula saving. Evonik Oil Additives investor presentation, January 2025, accessed 2026-08-27.

Market size and growth

There is no authoritative current public market census. IHS estimated a roughly $14 billion global lubricant-oil-additives market in 2015 with 1%–2% annual growth; a European industry committee described an EUR11.7 billion market in 2014. Assumption: applying 1%–2% annual real or volume growth and the change in the U.S. chemical-manufacturing producer-price index to the $14 billion base yields a directional 2026 global lubricant-additives market of $22.5–$25.1 billion. This is a transparent current-dollar bridge, not a fresh survey. On that range, Afton’s $2.156 billion of lubricant-additive revenue represents about 9% of global value. Chemical Week/IHS feature, 2015; BLS chemical-manufacturing PPI via FRED, accessed 2026-08-27.

The industry’s more important characteristic is slow physical growth. Vehicle parc and miles traveled support engine-oil demand, but smaller engines, longer drain intervals, fuel economy, and electrification reduce fluid use per vehicle. Industrial demand tracks production and GDP. Higher-performance specifications and regional price/mix can grow value even if treated volume is flat. The resulting base case is low-single-digit value growth, not a high-volume secular compounder.

Electric vehicles illustrate the difference between new sales and the installed base. More than 20 million electric cars were sold globally in 2025, exceeding 25% of new-car sales, but EVs were only about 5% of the global car stock. IEA, Global EV Outlook 2026, accessed 2026-08-27. Battery-electric vehicles eliminate engine-oil changes and most fuel-additive use, while hybrids retain both and all powertrains need some driveline or thermal fluids. Electrification is therefore a delayed, compounding volume attrition risk rather than an immediate cliff. E-fluids transfer incumbent formulation skills but are not proven as a one-for-one revenue replacement.

Competitive concentration and barriers

Afton, Lubrizol, Infineum, and Chevron Oronite remain the four major global lubricant-package suppliers. NewMarket said the four supplied more than 80% of the market in 2006; IHS estimated roughly 90% in 2015; NewMarket still named the same four in 2025. NewMarket FY2006 Form 10-K, filed 2007-02-27; NewMarket FY2025 Form 10-K, accessed 2026-08-27. The exact current shares and HHI are not public, so the historic concentration figures should not be repeated as current estimates. The unchanged roster is the stronger evidence: no entrant displaced a full-package incumbent across roughly two decades.

Qualification is costly and slow. A European Commission decision documented formulation-specific approvals that historically took one month to more than a year, typically about six months, with typical accreditation cost of $200,000–$400,000 and possible cost in the millions; separate interchange programs could cost $100,000–$1 million. Those dollar figures are old, but the mechanism remains current: OEM approvals attach to tested formulations and modern API, ACEA, engine, rig, and bench tests remain specific and expensive. European Commission Decision 2004/284/EC, accessed 2026-08-27; API engine-oil licensing, accessed 2026-08-27.

Fuel additives are less concentrated and generally less captive. Afton competes with BASF, Innospec, Lubrizol, Oronite, Infineum, Clariant, Dorf Ketal, and regional suppliers depending on the application. The proper industry verdict therefore applies most strongly to lubricant packages, not uniformly to every petroleum-additive product.

Marathon supply-side assessment

Petroleum Additives sits in a mature, disciplined capital cycle. Afton’s additions to long-lived assets were $75.6 million in 2025 and $72.1 million in 2024 versus D&A of $79.6 million and $79.2 million, or roughly 0.95 times and 0.91 times. Slow demand, high qualification cost, and an established four-firm structure deter greenfield full-package entry. That is far healthier than a commodity chemical cycle in which lumpy world-scale capacity clears through price.

The supply side is not frozen. Oronite is expanding in Ningbo, Infineum has added local blending in India, Lubrizol acquired land for a large Indian site, and BASF is expanding antioxidant-component capacity in Mexico. These projects are mainly incumbent localization, blending, debottlenecking, and component additions rather than new global package platforms. They still matter in a 1%–2% growth market: multiple regional additions can pressure price even if no new full-service rival appears. Chevron Oronite Ningbo announcement, 2024-05-22, accessed 2026-08-27.

Specialty Materials is in the opposite phase. NewMarket has committed about $1 billion since 2024 to two acquisitions and capacity expansion. AMPAC is building an up-to-$100 million line intended to raise ammonium-perchlorate capacity by more than 50%, with start-up expected near year-end 2026. Qualification, national-security sourcing, and limited producers may support returns, but the capital is being installed ahead of demonstrated utilization. Strong defense and space demand is precisely the environment in which a protected niche can attract excessive capital. The relevant evidence is contracted demand, ramp utilization, and incremental return—not the end-market growth narrative.

Verdict: Lubricant packages are a structurally attractive, slow-growth oligopoly with customer captivity plus scale and a stable-to-mildly expansionary supply side. Fuel additives are less defensible. Specialty Materials has stronger barriers but is entering an expansion phase whose economics remain untested. Industry structure protects returns; it does not create enough organic growth to justify any valuation.

4. Competitive Position and Moat Test

Greenwald taxonomy

The central advantage is demand captivity reinforced by economies of scale. A customer’s switching cost includes formulation search, laboratory and engine testing, API or OEM claims, reblend validation, production conversion, field risk, and supply qualification. These costs do not make switching impossible, but they make changing a working package for a small price saving irrational. The relationship is strongest in OEM-specific engine-oil and driveline formulations, moderate in broader lubricant and fuel applications, and weaker in commoditized additive niches.

Scale reinforces that captivity. A new global entrant would need laboratories, engine and rig capacity, years of performance data, OEM relationships, customer technical teams, and local production or supply resilience before it had enough qualified volume to spread the fixed cost. Afton spent 5.2% of segment sales on R&D/testing in 2025 and maintains a global technical network. The relevant scale is not NewMarket’s total corporate size; it is share and fixed capability within each formulation market. Afton is smaller than some integrated-parent rivals but still belongs to the global tier.

Patents, formulas, trade secrets, and employee knowledge are supporting supply advantages, not a complete moat. About 18% of employees had more than 20 years of service at year-end 2025, and roughly 1,400 patents were issued or pending. Chemistry can be imitated and patents expire. The durable system is know-how plus accumulated data, qualification, customer integration, and reliable production. There is no network effect: one customer’s use does not directly increase another customer’s product utility.

Outcome tests

The financial outcome is consistent with an advantage. Petroleum-additive segment margins held between 19.1% and 22.5% in 2023–25 despite raw-material and supply volatility, and filing-rebuilt consolidated ROIC was 23.6% in both 2023 and 2024. Even after acquisition capital and petroleum normalization, FY2025 ROIC was 16.6%. Those returns clear Greenwald’s qualitative hurdle for a franchise; the 2021–22 trough proves the moat is not an instantaneous cost shield.

H1 2026 provides a sharper pricing test. Petroleum shipments fell 5.3%, while price/mix and foreign exchange offset the decline and segment profit rose. Q2 price/mix of $29.6 million included conflict-related surcharges and more than covered a $10.1 million shipment drag. Interpretation: customers accepted cost recovery and Afton exercised value-over-volume discipline. Open question: management’s statement that the volume decline substantially reflected pruning is not independently verifiable. Persistent lost volume after surcharges reverse could mean share loss rather than discipline.

Rival comparison

Competitor evidence shows comparable capability. Infineum received a new Stellantis approval in April 2026, and Oronite is adding regional production. Infineum approval announcement, 2026-04-30; Chevron Oronite Ningbo expansion, 2024-05-22, accessed 2026-08-27. These facts prevent an overstatement: Afton has a durable seat in a shared oligopoly, not a uniquely dominant technology.

Specialty Materials moat and limits

AMPAC and Calca’s barriers combine process knowledge, safety regulation, program qualification, limited qualified sites, purity, audit history, and mission heritage. The asymmetric failure cost is extreme, and national-security rules can limit foreign substitution. In Greenwald terms, customer captivity is program-specific and reinforced by scarce qualified supply. These barriers may be stronger than Afton’s, but they are tied to narrow products and individual facilities.

The counter-case is concentration. An outage at AMPAC’s Utah site or Calca’s Louisiana site can interrupt the entire business line. Government budgets, prime-contractor schedules, environmental permits, hazardous-material handling, and qualification of alternate sources can move demand or cost. Regulation supports entry barriers while simultaneously increasing catastrophic operational risk. And because NewMarket paid acquisition premiums for the franchises, their attractive industry economics do not automatically translate into attractive shareholder returns.

Disconfirming evidence

The current market-share stability test is unavailable. Customer retention, dual-source rates, and qualification duration are not disclosed. Petroleum sales declined in both 2024 and 2025, and 2025 shipments fell 4.9%. Afton’s long-run sales increased from about $2.125 billion in 2015 to $2.534 billion in 2025, only 1.8% nominal annually. A genuine moat therefore protects economics more clearly than it creates growth. Any claim of an unassailable advantage would be inconsistent with the 2021–22 margin squeeze, powerful oil-company customers, comparable rival capabilities, and long-run volume pressure.

Verdict: NewMarket has a durable but shared competitive advantage. The mechanism is qualification-driven customer captivity plus fixed technical and supply scale, not patents, brand, or network effects. The advantage supports high returns and cost recovery but cannot eliminate volume attrition, input-cost lags, buyer power, or the need for continuous reinvestment.

5. Growth History and Forward Opportunities

Historical growth: economics outpaced the top line

NewMarket’s five-year revenue record is respectable but not a conventional growth story. Consolidated revenue increased from $2,356.1 million in 2021 to $2,725.2 million in 2025, a 3.7% compound rate, but the path was dominated by inflation, pass-through, and acquisitions. Revenue peaked at $2,786.6 million in 2024 and declined 2.2% in 2025. Petroleum Additives sales declined from $2,689.7 million in 2023 to $2,636.2 million in 2024 and $2,533.6 million in 2025. Over a decade, petroleum sales rose from roughly $2.125 billion in 2015 to $2.534 billion in 2025, only about 1.8% nominal annually. NewMarket FY2015 Form 10-K, filed 2016-02-26; NewMarket FY2025 Form 10-K, accessed 2026-08-27.

Earnings grew much faster because margins recovered. Consolidated operating profit increased from $257.8 million in 2021 to $543.7 million in 2025, and operating margin from 10.9% to 20.0%. That is economically valuable, but it is not repeatable at the same rate once raw-material recovery and operating normalization are complete. An investor who extrapolates the 2021–25 EPS CAGR is implicitly assuming another large margin expansion from a base already near the franchise’s observed high.

Afton opportunities: specification, mix, and adaptation

The highest-quality near-term growth opportunity is continued value-over-volume improvement. New engine-oil, driveline, industrial, and fuel specifications raise formulation difficulty and value per treated unit. Afton can win by helping customers meet GF-7, OEM-specific driveline requirements, lower-viscosity standards, and increasingly complex materials-compatibility needs. This growth is attractive because it uses existing laboratories, data, customer relationships, and plants; incremental capital requirements are moderate.

The counterweight is that specification upgrades can increase value without increasing physical demand. Longer drain intervals let a better oil remain in service longer. Smaller engines require less fill. Afton can take price or mix share and still face flat industry volume. The forward model should therefore separate volume, price, mix, and share rather than use a single revenue CAGR.

E-mobility is a necessary adaptation. Afton markets fluids designed for electrical conductivity, copper compatibility, high-speed friction, noise, thermal management, and hybrid or battery-electric drivelines. Afton eMobility, accessed 2026-08-27. The technical capability transfers from conventional driveline chemistry, but Lubrizol, Infineum, and Oronite are pursuing similar work. Interpretation: e-fluids help preserve relevance and customer relationships; they are not yet a disclosed incremental growth pool. The evidence needed is qualified program wins, revenue, content per vehicle, and margins.

Emerging markets and the global installed vehicle parc can delay decline. Commercial, marine, off-road, and industrial equipment electrify more slowly than light-duty vehicles. Hybrids retain engine oil and fuel-related needs. Afton can also gain regional share through technical support and local supply. None of these offsets should be assumed without segment or product disclosure, which NewMarket currently does not provide.

Specialty Materials opportunities: acquired scarcity and new capacity

Specialty Materials has faster reported growth. FY2025 sales of $182.5 million included only one quarter of Calca. H1 2026 sales rose 30.8% to $125.3 million, but the comparison includes Calca only in the current period and operating profit rose just 3.3%. Q2 performance was strong while Q1 suffered unfavorable AMPAC shipment mix. The quarterly record supports genuine demand but not a clean organic CAGR.

The AMPAC line is intended to increase ammonium-perchlorate capacity by more than 50% for up to $100 million, with start-up around year-end 2026. NewMarket also says added high-purity-hydrazine capacity should come online around the same time. NewMarket Q2 2026 earnings exhibit, 2026-07-29, accessed 2026-08-27. Qualification constraints, U.S. defense priorities, commercial-space activity, and limited qualified production could make these excellent projects.

The Marathon capital-cycle warning is equally plausible. AMPAC’s FY2023 stand-alone revenue was $124.0 million, and two customers accounted for 68% of sales and 81% of receivables. A more than 50% capacity increase against that concentrated base magnifies program and utilization risk. AMPAC audited FY2023 financial statements, filed 2024-02-28, accessed 2026-08-27. NewMarket does not disclose backlog, take-or-pay protections, committed volume, expected incremental EBITDA, or project return. The growth may be attractive; the public evidence cannot yet establish its quality.

Organic versus acquired growth scorecard

Verdict: Petroleum growth is low but can be high quality when driven by specification, mix, and disciplined pricing. Specialty Materials can accelerate consolidated growth, but it is purchased and capital-intensive. The company has not yet disclosed enough to distinguish value-creating scarcity expansion from growth that merely enlarges the asset base.

6. Financial Quality

Five-year filing rebuild

Sources: audited comparative statements in NewMarket FY2025 Form 10-K, filed 2026-02-12, and FY2022 Form 10-K, filed 2023-02-15, accessed 2026-08-27. FCF is analyst-defined CFO less property, plant, and equipment purchases.

The table shows three separate economic stories. First, the 2021–22 input shock compressed gross margin even as revenue rose through price. Second, 2023–24 delivered the delayed recovery: gross margin expanded 865 basis points from 2022 to 2024, and operating profit rose 66%. Third, FY2025 normalized from a peak while the balance sheet absorbed Calca and continued buybacks. The through-cycle improvement is real, but the record does not support a straight-line extrapolation.

Current run rate and segment economics

Q2 2026 revenue increased 7.0% to $747.1 million, gross profit 9.7% to $242.4 million, operating profit 14.3% to $163.7 million, and net income 20.2% to $133.8 million. H1 results were less dramatic: revenue grew 1.2%, gross profit 1.4%, operating profit 1.3%, and net income 6.2%. H1 operating margin was essentially flat at 21.66%. NewMarket Q2 2026 Form 10-Q, filed 2026-07-30.

The quarter should not be called a volume turn. Petroleum shipments remained down, and the profit improvement was driven by pricing and Middle East surcharges. Specialty growth included acquired Calca and favorable Q2 program mix. H1 Specialty Materials operating margin fell from 35.2% to 27.7%, even though Q2 margin rose to 33.3%. The six-month view is the cleaner warning against capitalizing one favorable quarter.

Cash conversion and working capital

Five-year cumulative CFO was $1,939.3 million and FCF was $1,621.0 million, equal to 111% and 93% of cumulative net income. That is strong cash quality. The annual pattern is volatile because working capital absorbed $116.4 million in 2021 and $204.6 million in 2022, then released $134.3 million in 2023, including a $192.5 million inventory reduction. High input prices and safety-stock decisions built inventory; normalization released real cash. One should not treat 2022’s 19% FCF conversion or 2023’s 136% as a permanent run rate.

H1 2026 CFO was $286.2 million, up 1.7%, while capex rose 76.6% to $51.7 million and FCF declined 7.0% to $234.4 million. CFO was 114% of net income and FCF 93%. Accounts receivable and inventory rose, but accounts payable increased to $341.6 million and offset most of the use. Net working capital was almost unchanged at about $640 million. The company narrowed 2026 capex guidance to $100–$130 million, reflecting the Specialty Materials buildout.

U.S. petroleum inventory uses LIFO. At December 2025, it was carried at $138 million, $91 million below replacement cost. That reserve means book working capital understates current replacement economics. The filing identified no material LIFO liquidation gain, so the earnings record is not flattered by a large old-cost release.

Returns on capital

Filing ROIC is after-tax operating profit divided by average borrowings plus equity less cash. It excludes leases for consistency with filed borrowings; the vendor includes a broader capital scope. The direction is more important than the exact construction. Returns consistently above the cost of capital corroborate the moat, while the 2025 decline quantifies the burden imposed by acquisitions. The central financial question is whether Specialty Materials lifts the numerator enough to earn on the enlarged denominator by 2027–28.

Balance sheet and liquidity

At 2026-06-30, filed borrowings were $854.8 million and cash was $93.6 million, for $761.2 million of net debt. The company had $309 million drawn on a $900 million revolver due 2029 and about $589 million of unused capacity net of letters of credit. Fixed debt consisted of $150 million of 3.78% notes amortizing $50 million in each of 2027, 2028, and 2029, plus $400 million face value of 2.70% notes due 2031. NewMarket Q2 2026 Form 10-Q, accessed 2026-08-27.

Bank-defined leverage was 1.20 times against a normal 3.75 times maximum. At unchanged debt, covenant EBITDA would need to decline by roughly two-thirds from the implied current level before the ordinary maximum was approached. That sensitivity is directional because credit-agreement definitions differ from GAAP, but the conclusion is robust: financing risk is low under ordinary cyclicality.

Earnings-quality adjustments

GAAP operating profit is a clean anchor. Revenue is point-in-time with small rebate true-ups, stock compensation was only $3 million in 2025, the auditor issued an unqualified opinion, and no restatement or material weakness appeared in the five-year filing sweep. The review covered five 10-Ks, 15 10-Qs, 52 8-Ks, five proxies, and 82 Form 4s among 189 SEC documents. Each earnings exhibit incorporated by an 8-K was checked directly on SEC.gov.

Three adjustments require care. First, FY2025 non-service pension/postretirement income was about $53.0 million, 94% of other income and 9.5% of pretax income. The $605.4 million June 2026 prepaid pension asset is economically real, but an 8% expected-return assumption and actuarial markets make the annual P&L contribution non-operating and non-cash. Second, amortization rose from $2.0 million in 2023 to $28.4 million in 2025 and should approximate $37 million annually through 2030. This is non-cash, but it reflects purchased customer and formula assets and should not be automatically excluded from economic earnings. Third, AMPAC’s Q1 2024 inventory step-up caused acquired inventory to produce no accounting margin; that specific effect is one-time.

The filings also identify 2025 network-optimization items that management excluded from bonus operating profit. It is appropriate to isolate a quantified one-time charge, but not to normalize market softness, shipment decline, technology investment, lower plant utilization, recurring amortization, or government-program mix. Those are operating economics.

Verdict: Financial quality is high: strong cumulative cash conversion, genuine operating margins, minimal dilution, high returns, and ample liquidity. It is not pristine: annual cash conversion is inventory-sensitive, reported EPS contains a material pension tailwind, and acquisition capital has already reduced ROIC. Economics improved with scale and price recovery, but future improvement depends on specialty utilization rather than further easy margin recapture.

7. Capital Allocation, Management, and Governance

Historical deployment

From 2021 through 2025, NewMarket generated $1.939 billion of CFO, invested $318 million in capex, paid approximately $895 million for acquisitions net of acquired cash, distributed $457 million in dividends, and used about $556 million for repurchases. The funding mix was disciplined: the company used debt around acquisitions, issued no material equity, and then reduced leverage. NewMarket FY2025 Form 10-K, accessed 2026-08-27.

Repurchases created real per-share value rather than merely offsetting SBC. Year-end shares declined from 10.921 million in 2020 to 9.397 million in 2025 and 9.196 million by June 2026. Annual average accounting costs were about $346, $310, $363, $531, and $542 per share in 2021–25. H1 2026 repurchases used $126.4 million for 204,927 shares, mostly in Q1 at about $617. The company bought only 1,384 shares in April and none in May or June as the price rose, leaving $301.8 million under the authorization. Outcome is not proof of process, but the record is the opposite of a pro-cyclical program.

The dividend per share increased from $8.00 in 2021 to $11.25 in 2025, an 8.9% CAGR. The current $3.00 quarterly rate implies $12 annually and remains well covered by earnings and cash generation. Dividends and buybacks together return capital while the core needs only maintenance-like investment.

M&A scorecard

AMPAC entered at a plausible but not cheap 11.5 times pre-deal EBITDA. Its audited FY2023 income statement showed $39.1 million of interest expense against $42.4 million of operating income under the former capital structure. Two customers represented 68% of sales. NewMarket gained a strategically scarce asset but accepted concentration and single-site risk. AMPAC audited financial statements, filed 2024-02-28.

The initial pro forma combination was dilutive before synergy or growth: transaction-accounting adjustments reduced pro forma operating profit, and pro forma FY2023 net income was $368.3 million versus NewMarket’s $388.9 million stand-alone. Management expected accretion, but the more relevant test is return on the $697 million purchase plus capacity. AMPAC/Calca segment aggregation prevents that calculation.

Calca is still harder to score. The $218 million price was funded with cash and revolver borrowing; no stand-alone revenue, EBITDA, backlog, or multiple was disclosed. At Q2 2026, purchase accounting remained provisional. The auditor identified the customer-base intangible valuation as a critical audit matter because it depends on revenue growth, EBITDA, discount rate, and attrition assumptions. The accounting does not prove overpayment, but it makes tangible downside support thin.

Incentives and ownership

CEO Thomas E. Gottwald received $3.695 million of 2025 summary compensation. The annual bonus starts from adjusted operating profit as the sole formulaic maximum, then the committee applies subjective discretion. For 2025, bonus-plan operating profit was $571 million versus $544 million GAAP after excluding $10.8 million of bonus expense and $16.5 million of one-time items; the CEO received $750,000 versus a roughly $2 million maximum. Negative discretion and modest pay are favorable.

Long-term performance stock uses adjusted EPS in the fifth year, with zero below threshold and a capped payout at target. The five-year horizon is sound, but the target is undisclosed and there is no ROIC, cumulative FCF, or relative-TSR criterion. Debt-funded acquisitions and repurchases can raise EPS even when incremental returns disappoint. This mismatch is material precisely because NewMarket is allocating roughly $1 billion to a new segment. NewMarket 2026 DEF 14A, filed 2026-03-12, accessed 2026-08-27.

Ownership creates both alignment and control. Bruce C. Gottwald owned 945,587 shares, or 10.1%, explicitly excluding adult sons’ 915,816 shares, or 9.7%, which include CEO Thomas Gottwald’s 559,605 beneficially owned shares, and excluding 272,835 shares, or 2.9%, in separate family trusts. Those three non-overlapping proxy buckets sum to about 22.7% of outstanding shares; Thomas should not be added again. The CEO’s 6% beneficial ownership stake matters far more than annual pay.

Governance and related parties

NewMarket has one voting class and five of seven directors are independent. The CEO is also chairman, however, and EVP/CAO Bruce Hazelgrove became a second non-independent director in February 2026 after Bruce C. Gottwald retired. The independent lead director approves agendas and presides over executive sessions, but the board has no policy separating chair and CEO.

Succession is an open issue. Thomas Gottwald is 65 and has led the predecessor or NewMarket since 2001/2004. The lead director is 75, another independent director is 80, and independent-director average tenure is roughly 12 years. No CEO succession timetable is public. Continuity has produced strong results, but a long-tenured family-influenced board can become less willing to challenge a strategic pivot.

Six relatives of the CEO or CAO received about $2.65 million of 2025 compensation. Four of the CEO’s sons held roles including President of Ethyl, EVP Specialty Materials, and SVP Procurement and Data Intelligence; one received a $350,000 separation payment. Another bought a company-owned residence for a disclosed $1.2 million fair value. The Audit Committee reviews related transactions case by case, but the proxy says the company has not adopted formal procedures or approval standards. These disclosures do not prove abuse; they justify an entrenchment and oversight discount.

Insider transactions

The trailing five-year Form 4 corpus contains one open-market purchase: independent director Ting Xu bought 400 shares at $619.21 on 2026-02-24, about $248,000, without a 10b5-1 plan. The last open-market sale was Hazelgrove’s planned 311-share sale at $642.43 in May 2025. CEO Thomas Gottwald made the largest discretionary sale in the window, 8,100 shares for about $5.23 million in March 2024 at roughly $643–$650, with no 10b5-1 flag; he has not followed it with another sale. Ting Xu Form 4, filed 2026-02-25, Bruce Hazelgrove Form 4, filed 2025-05-14, and Thomas Gottwald Forms 4 filed 2024-03-06, 2024-03-07, and 2024-03-08, accessed 2026-08-27.

Interpretation: current insider evidence is modestly positive, not a broad buying signal. Most other filings are grants, withholding, gifts, and trust transfers. The CEO’s existing stake and the director’s post-drawdown purchase matter; neither can substitute for operating evidence.

Verdict: Legacy allocation is above average: accretive share shrink, well-covered dividends, modest SBC, and rapid balance-sheet repair. The verdict on management now depends on the roughly $1 billion Specialty Materials program. Missing ROIC/FCF incentives, limited acquisition disclosure, family employment, and succession opacity make future return evidence more important than historical goodwill.

8. Changes and Headwinds — Last Two Years

The most important change is strategic, not cyclical. NewMarket moved from an almost pure petroleum-additives company to a two-segment portfolio through AMPAC in January 2024 and Calca in October 2025. The purchases added mission-critical defense and space exposure, $915 million of consideration, substantial acquired intangibles, and a new capacity cycle. The strategic rationale—similar safety, technical, regulatory, and qualification cultures—is plausible. The economic adjacency remains a hypothesis until segment returns are visible.

Second, Petroleum Additives shifted explicitly toward value over volume. FY2025 shipments declined 4.9%, and management attributed part of the decline to market softness and deliberate reduction of low-margin business. Q1 2026 shipments fell another 7%. Q2 profit recovered through surcharges rather than volume. The favorable interpretation is disciplined oligopoly behavior; the adverse interpretation is lost share or structural attrition being relabeled as pruning. Independent share and customer-retention data would adjudicate it.

Third, Specialty Materials moved from acquisition to execution. AMPAC’s added line and expanded hydrazine capacity are expected around year-end 2026. Commissioning can create downtime, inefficiency, working-capital needs, and delayed qualification before utilization rises. H1 2026 capex increased 77%, while specialty operating profit was almost flat year over year despite acquired revenue. The next 18 months will shift the debate from strategic narrative to throughput and return.

Fourth, leadership and board composition changed. CFO William Skrobacz retired and Timothy Fitzgerald became CFO in January 2025. Controller Ann Pietrantoni resigned in November 2025, with a permanent successor appointed in February 2026. Bruce C. Gottwald retired from the board in December 2025, and Hazelgrove joined in February 2026 as a non-independent director. No departure was described as involving disagreement, and the SEC sweep found no auditor change, restatement, control weakness, or governance rupture.

The full sequence of 20 quarterly earnings exhibits from Q3 2021 through Q2 2026 resolves into four phases: input costs overwhelmed pricing through early 2022; price and portfolio actions restored profit through 2023 despite destocking; 2024 produced peak petroleum economics while AMPAC purchase accounting obscured early specialty results; and 2025–H1 2026 combined weaker core volume with acquired specialty contribution and Q2 surcharges. This chronology matters because the latest quarter is not a clean new cycle: H1 petroleum operating profit rose only 0.9%, and the October 2025 share-price decline preceded the October 30 earnings release, so it cannot be attributed to that print without separate evidence. NewMarket Q2 2026 earnings exhibit, 2026-07-29, accessed 2026-08-27.

Fifth, the regulatory and demand backdrop is mixed. GF-7 raised engine-oil performance complexity in 2025, supporting technical value. U.S. vehicle greenhouse-gas policy loosened in February 2026, potentially slowing one source of specification pressure, while OEM, API, ACEA, and non-U.S. standards continue. U.S. EPA final action, 2026-02-12, accessed 2026-08-27. Electrification remains a long-duration demand headwind rather than a near-term collapse. Defense and space demand support Specialty Materials but expose it to appropriations, contract modification, program mix, and government shutdown timing.

Sixth, Middle East disruption changed the latest quarter’s economics. Q2 pricing included surcharges designed to cover higher raw-material and operating costs. This is evidence of pass-through capability, not clean base-price growth. When disruption costs reverse, the company may remove surcharges; treating them as recurring revenue would overstate the run rate. The latest earnings-call record contained prepared remarks but no analyst Q&A, leaving capacity commitments, organic Specialty Materials growth, and surcharge duration untested in public dialogue. ROIC.ai NEU transcript record, accessed 2026-08-27.

Verdict: The last two years strengthened diversification and exposed a potentially better niche, but they also replaced a known capital-allocation model with an unproven one. Core margin resilience is favorable; persistent volume weakness, acquisition opacity, commissioning risk, and governance continuity keep the net effect unresolved.

9. Risk Analysis

Principal downside pathways

The most plausible downside is not insolvency. It is a simultaneous normalization of petroleum margin and valuation while Specialty Materials fails to fill capacity. A 100-basis-point change in Afton margin on about $2.5 billion of sales changes EBIT by roughly $25 million. A move from 20% to 17.5% would reduce operating profit by about $63 million before secondary effects; a lower terminal multiple would amplify the equity impact.

Operational concentration creates lower-probability, higher-severity risk. Some Afton products and specialized inputs are single-site or single-source, while AMPAC and Calca depend on individual facilities handling hazardous materials. A major explosion, contamination, regulatory shutdown, or long outage could interrupt qualified supply, impair customer programs, and require a lengthy alternate-site approval. Insurance and inventory can reduce loss but cannot instantly replace mission history.

Customer concentration is hidden by consolidation. No consolidated customer exceeds 10% of revenue, yet AMPAC’s stand-alone top two customers represented 68% of sales and 81% of receivables in FY2023. A change in one program, prime contractor, appropriation, or delivery schedule can move quarterly segment profit sharply. The risk is not necessarily customer defection; program timing alone can create earnings volatility.

Acquisition accounting creates an impairment pathway. AMPAC and Calca consideration was assigned mainly to customer relationships, formulas, trademarks, water rights, and goodwill. No impairment has been recognized. If the capacity ramp, customer retention, or projected growth disappoints, the balance sheet has limited tangible support. An impairment would be non-cash at recognition but would reveal that acquisition returns were overestimated.

Governance risk is subtle. The Gottwald family’s ownership aligns wealth with per-share outcomes, and management’s historical decisions were good. But family employment, no formal related-party standards, a combined chair/CEO, a second executive director, and no disclosed succession timetable can reduce challenge exactly when the company is entering a new industry. EPS-based long-term compensation compounds the risk by rewarding buybacks and acquisition growth without directly testing incremental return.

Total-loss risk is remote under the current balance sheet. Net leverage is low, maturities are staggered, the core generates cash, and essential formulations retain customer value. Catastrophic plant loss across multiple sites, severe legal or environmental liability, or a prolonged collapse in the core combined with debt-funded expansion would be required for that outcome. Ordinary permanent-loss risk comes primarily from paying a premium for peak earnings and poor reinvestment, not from near-term liquidity.

Verdict: The key risks are economic and valuation-related rather than financial. Petroleum volume and margin normalization, specialty utilization, and acquisition returns dominate. Balance-sheet strength lowers the chance of forced loss but cannot protect the buyer from multiple compression or capital misallocation.

10. Valuation and Embedded Expectations

Valuation begins with a live enterprise value rather than a fiscal-period vendor snapshot. At the 2026-08-26 close of $925.33 and 9.196 million June basic shares, equity value was $8,509.7 million. Adding $854.8 million of filed borrowings and subtracting $93.6 million of cash produces $9,270.9 million of enterprise value. Including $85.1 million of lease liabilities would raise it to $9,356.0 million. TTM revenue, EBITDA, operating profit, and net income through June were approximately $2,742.5 million, $676.2 million, $547.6 million, and $433.4 million. NewMarket Q2 2026 Form 10-Q, filed 2026-07-30; AZI NEU adjusted daily-history CSV, pulled 2026-08-27.

ROIC.ai’s TTM EV uses a fiscal-period market capitalization and understates current EV by about $1.15 billion, or roughly 1.7 turns of EBITDA. It is rejected as the live anchor. Date-matched history remains informative: 2014–25 median EV/EBITDA was 12.5 times and the 75th percentile 13.45 times; median EV/EBIT was about 14.8 times and the 75th percentile 16.3 times. Current multiples sit above both 75th-percentile marks but below past extremes. ROIC.ai NEU valuation history, accessed 2026-08-27.

Method 1: normalized earnings power

Assumption: a through-cycle operating base of $510–$530 million is more defensible than the $590 million FY2024 peak or $258 million FY2021 trough. It assumes Afton sustains an 18.5%–20.0% margin, Specialty Materials contributes $50–$65 million before full capacity credit, and corporate costs remain in the low $20 millions. A 24% tax rate produces $388–$403 million of NOPAT. After considering D&A, maintenance capex, and recurring acquired-intangible amortization, normalized unlevered cash earnings are approximately $400–$420 million.

At an 8.0%–9.0% WACC, no-growth enterprise earnings power is $4.44–$5.25 billion. Adding an approximate $460 million after-tax value for the prepaid pension asset and subtracting net debt produces equity earnings-power value of about $450–$540 per share. This method deliberately assigns no value to growth and understates a genuine franchise. Its purpose is to quantify how much of the current capitalization depends on future growth and persistent excess returns: quoted equity is about 1.7–2.1 times modeled no-growth value.

TTM EPS of $46.41 includes an estimated $4.5–$4.8 per share after tax of non-service pension benefit. Removing it produces core earnings around $41.5–$42.0. A 15–17 times normalized earnings frame plus the after-tax pension asset produces roughly $675–$765 per share. Normalized owner cash of $420–$450 million produces a 4.9%–5.3% yield at the current equity value. These are analytical ranges, not targets.

Method 2: peers, history, and segment value

NEU deserves a premium to ordinary chemical companies because its EBITDA margin is 24.7%, operating margin is 20.0%, and qualification creates captivity. A live peer frame rebuilt from current prices and latest balance-sheet data—but not subjected to a full peer-filing audit—places IOSP at 12.4 times EBITDA, FUL at 8.7, RPM at 14.0, PPG at 11.3, ECL at 23.1, and ASH at 13.2. NEU at 13.7 times is close to RPM, above lower-margin formulators, and far below ECL’s stronger service-embedded model. The peer screen recognizes quality; it does not reveal an obvious discount.

Segment EBITDA is estimated because quarterly D&A by segment is not disclosed. Each case subtracts $761 million net debt and divides by 9.196 million shares. The current enterprise value is almost identical to the generous case. If Specialty Materials is worth $1.2–$1.4 billion, Afton receives roughly 13–14 times normalized EBITDA. If Afton receives 12 times, the residual specialty value is about $2.2 billion—more than twice acquisition consideration plus the announced line. Either allocation requires a premium assumption.

Method 3: five-year scenarios

All forward inputs are analyst assumptions, not company guidance or consensus. The base is operationally respectable: Afton grows through price/mix and holds 20% margins, Specialty compounds at 12%, leverage declines, and shares shrink. It still produces only 2.5% annualized total return from the reference price. The bull requires both durable 22% Afton margins and an 18% Specialty CAGR to a 30% margin, plus a 14 times terminal multiple. The bear does not require collapse—only volume attrition, 17.5% Afton margin, slower specialty ramp, and multiple normalization.

Reverse expectations

Using $420–$445 million of enterprise cash earnings and an 8.5% WACC, the $9.27 billion live EV implies perpetual growth of roughly 3.5%–3.8%. That is materially above Afton’s 1.8% nominal 2015–25 sales CAGR. The gap must be filled by permanently high margins, Specialty Materials growth, per-share shrink, and no severe terminal damage from electrification.

Sensitivity is high. Each 100 basis points of Afton margin changes EBIT by about $25 million and after-tax earnings by roughly $19 million. Moving Specialty EBITDA from $90 million to $120 million can change value by about $40–$50 per share at premium multiples. One turn of terminal EBITDA on a $700–$800 million year-five base changes enterprise value by $700–$800 million, or about $80–$90 per projected share.

Verdict: The market is correctly treating Afton as a franchise and Specialty Materials as more than commodity capacity. It may be incorrectly treating current petroleum margins as a floor, acquired growth as organic, and pension income as operating. Current valuation leaves limited room for ordinary execution and depends on both durable core economics and a successful specialty ramp.

11. Variant Perception

The apparent consensus is that NewMarket has completed its pass-through recovery, now deserves a quality-specialty multiple, and has added a scarce defense-and-space growth platform without compromising the balance sheet. That belief is supported by H1 petroleum margin above 22%, net leverage around one turn, aggressive share shrink at lower prices, and mission-critical acquired products. The tape has moved from valuing a hidden chemical compounder to capitalizing its margins as durable.

The strongest bull case is internally coherent. The four-firm lubricant-package oligopoly prunes low-return volume and keeps Afton margin above 20%. Specifications and fleet complexity offset physical attrition in value terms. AMPAC and Calca use qualification barriers to fill new capacity at 25%–30% operating margins, lifting specialty EBITDA above $120 million. Cash flow then funds dividends, debt reduction, and 1%–2% annual share shrink. Under this case, the current multiple reflects a durable two-franchise compounder rather than peak earnings.

The strongest bear case is also coherent. Petroleum volume pruning masks share loss and long-run ICE-fluid attrition. Conflict surcharges fade, plant utilization weakens, and Afton margin normalizes toward 17%–18%. Defense and space demand remains healthy but AMPAC’s concentrated customers delay programs, leaving the new line underutilized. Acquired intangibles fail to earn their cost of capital, while EPS-based incentives still reward buybacks and scale. A quality multiple then compresses even though the company remains solvent and profitable.

The variant view is that business quality and growth quality have diverged. Afton’s moat is better proven than the market once recognized, but its organic growth remains low. Specialty’s growth is faster but its returns are less proven. The stock price merges the two favorable attributes as though each segment possesses both. That synthesis is possible, not demonstrated.

Factor positioning strengthens this reading. The base model loads on market, dividend yield, value, and small size, with only modest momentum loading. The all-factor model explains 19.8% of variance, beta is 0.59, and specific volatility is 30.9%. NEU is not a crowded chemical-factor proxy; it is an idiosyncratic, event-sensitive name whose recent momentum can reverse when earnings assumptions change. FactorsToday NEU model snapshots, pulled 2026-08-27.

Verdict: Consensus is probably right about moat and balance-sheet quality. It may be early on the second growth engine and too confident that recovered margins are permanent. The variant is not that NewMarket is a bad chemical company; it is that a mature franchise is being valued as though acquired growth has already passed its return test.

12. Fact vs. Interpretation

13. Open Questions and Monitoring Dashboard

1. What are Afton’s current shares in lubricant packages and fuel-additive submarkets by region, and how have they changed over five years?
2. How much of the FY2025 and H1 2026 shipment decline was deliberate low-margin pruning versus market contraction and competitive loss?
3. What are typical requalification time, cost, dual-source rate, and customer-retention duration for Afton’s principal programs?
4. What percentage of engine-oil exposure is light-duty versus slower-electrifying commercial, marine, and off-road equipment?
5. How much revenue and profit come from e-mobility fluids, and does content per electric vehicle offset lost engine-oil and fuel-additive content?
6. What were AMPAC’s and Calca’s stand-alone 2025–26 revenue, EBITDA, maintenance capex, and cash conversion after purchase accounting?
7. What customer commitments, take-or-pay protections, or qualified backlog support AMPAC’s more than 50% capacity addition?
8. What acquisition ROIC hurdle and synergy value did the board underwrite for AMPAC and Calca?
9. When does Specialty Materials exceed $100 million of sustainable EBITDA, and what incremental invested capital is required?
10. Will the board add ROIC or cumulative FCF to annual and long-term compensation before judging the expansion cycle?
11. What is the documented CEO succession process, and will board refreshment add independent defense-manufacturing and capital-allocation expertise?
12. Will NewMarket adopt formal related-party review standards rather than case-by-case procedures?

The quarterly dashboard should track petroleum shipment, price/mix, raw-material cost, segment margin, and R&D together; specialty organic revenue, operating profit, utilization, capex, and backlog separately; and consolidated ROIC, normalized owner cash, shares, net debt, and pension income. A single EPS figure obscures too many of the thesis variables.

14. What Must Be True — Falsification Audit

Bull case

For the favorable case to hold, Afton must sustain at least high-teens and preferably 20% operating margins through another input cycle without persistent qualified-share loss. Specialty Materials must absorb new capacity and exceed roughly $100–$120 million of sustainable EBITDA by 2028 while leverage remains modest. Consolidated acquisition-adjusted ROIC must recover toward 20%, and share shrink must continue without sacrificing balance-sheet discipline.

Bull falsification test: two consecutive years of consolidated or acquisition-adjusted ROIC below the low-to-mid teens after the AMPAC line ramps, Specialty EBITDA below $90–$100 million by 2028, or Afton qualified volume falling while margin depends on temporary surcharges would falsify the growth-compounder thesis.

Bear case

For the adverse case to hold, Afton’s qualification moat must prove unable to protect economics as ICE-fluid volume contracts and incumbent regional capacity grows. Margin must normalize toward 17%–18%, petroleum operating profit must decline toward or below $450 million, and Specialty capacity must remain underutilized or fail to cover acquisition capital. A lower quality multiple then follows from weaker growth and returns, not merely sentiment.

Bear falsification test: stable or rising qualified Afton volume with 20% or better margin through a raw-material cycle, disclosed Specialty organic growth with more than 20% incremental returns, and EBITDA above $120 million without leverage would invalidate the peak-margin/poor-M&A concern.

Governance test common to both cases

Return-based disclosure is part of falsification. If management provides stand-alone specialty EBITDA, maintenance capex, utilization, backlog coverage, and an explicit ROIC hurdle, investors can distinguish temporary purchase-accounting drag from weak economics. Continued opacity, especially alongside EPS-based pay and additional M&A, would itself weaken the favorable case even if reported EPS rises.

15. Research Conclusion

NewMarket passes the business-quality test and fails the easy-growth test. Afton occupies a durable place in a four-firm global lubricant-package oligopoly. Customers buy qualification, data, formulation skill, and reliable supply, while Afton spreads fixed R&D and testing over a global base. The result appears in recovered margins, high through-cycle returns, and strong cash generation. It is closer to a specialty service-like chemistry franchise than to a commodity molecule producer, though its moat is less embedded than Ecolab’s and its customers retain real bargaining power.

The moat protects economics more clearly than volume. Petroleum sales grew only 1.8% nominally over a decade, shipments weakened in 2025–26, and electrification plus longer drain intervals create a slow terminal headwind. Current margins reflect genuine pricing power but also sit near the top of observed history and include temporary surcharge effects. A mature franchise can remain an excellent business while offering limited incremental growth.

Specialty Materials is the bridge from that mature franchise to a growth narrative. AMPAC and Calca own credible mission-critical qualification barriers, and NewMarket has the balance sheet and operating culture to develop them. But approximately $1 billion of acquisition and capacity capital is already committed, purchase accounting is dominated by goodwill and intangibles, customer and site concentration are material, and stand-alone returns are undisclosed. The favorable industry story is evidence of opportunity, not evidence of value creation.

Historical allocation earns respect: well-timed share shrink, rising dividends, low SBC, and rapid deleveraging. Governance earns a mixed judgment. Large family ownership creates real alignment, while family employment, a combined chair/CEO, long board tenure, no formal related-party standards, and EPS-based incentives create entrenchment and reinvestment risk. The next scorecard should be ROIC and cash returns, not EPS alone.

At the reference price, investors are not paying for hidden quality. Live multiples already recognize the moat, and the current enterprise value nearly equals a generous segment case. A respectable operating base case does not produce an adequate modeled return, while the adverse case requires normalization rather than collapse. The institutional conclusion is therefore precise and position-free: NewMarket is a high-quality mature franchise whose valuation already assumes that an acquired second engine will convert scarce qualification into high-return growth. The core has earned that confidence; the new capital has not yet earned it.

APPENDIX A — Standard Diligence Questionnaire

General

What thoughtful questions should investors ask?

The first question is whether Afton’s petroleum-additives margin recovery reflects a durable oligopoly equilibrium or an unusually favorable point after delayed raw-material pass-through. Petroleum segment margin fell to 12.0% in 2021 and 13.7% in 2022, recovered to 19.1% in 2023 and 22.5% in 2024, slipped to 20.5% in 2025, and returned to 22.1% in H1 2026. The right diligence is not “does Afton have pricing power?”—the recovery demonstrates that it does—but how quickly it can reprice, how much volume is lost, and whether normalized margin is closer to the mid-teens or low-20s.

The second question is whether management is converting the mature petroleum franchise into a second high-return platform or merely purchasing defense/space growth at a premium. NewMarket paid approximately $697 million for AMPAC and $218 million for Calca, then committed up to $100 million to add more than 50% ammonium-perchlorate capacity. Investors need standalone organic sales, operating profit, maintenance capex, contracted/program demand, utilization, and incremental return data. Consolidated Specialty Materials results do not yet separate AMPAC from Calca.

The third question is why investors should capitalize current petroleum margins at an own-history P/S percentile near 99.5 when physical core demand is mature and eventually pressured by electrification and longer oil-drain intervals. A reasonable answer requires evidence of stable share, value-over-volume discipline, and specialty returns—not merely the observation that the stock has compounded.

Other important questions include: How long and costly is requalification for Afton customers, and how often do customers dual-source? Is H1 2026’s 5.3% shipment decline genuinely elective pruning or partly share loss? How much of the large prepaid pension asset is economically distributable? How concentrated are AMPAC and Calca by government program and physical site? Can the Gottwald family’s long-term orientation coexist with adequate minority-shareholder accountability? What revenue and margin does e-mobility actually contribute?

Primary sources for this section: NewMarket FY2025 Form 10-K, filed 2026-02-12, Q2 2026 Form 10-Q, filed 2026-07-30, and 2026 Definitive Proxy, filed 2026-03-12, accessed 2026-08-27.

Cyclicality and Earnings Nature

Are earnings at a cyclical high or low?

Interpretation: Petroleum earnings are above mid-cycle but not obviously at an unsustainable commodity peak. Afton is downstream specialty formulation rather than a globally clearing base chemical. Its current roughly 22% segment margin reflects recovered pass-through, product mix, pruning of low-margin volume, and disruption surcharges. The prior 2021–2022 trough proves pass-through is lagged; the 2023–2026 recovery proves qualification friction ultimately supports pricing. A prudent normalized case should sit below the best recent quarter and above the cost-shock trough.

Specialty Materials is in a different cycle: acquired earnings and new capacity are ramping into strong defense/space demand. Quarterly margins are volatile—33.3% in Q2 2026 but 27.7% for H1—and the group has not disclosed a clean organic bridge. Earnings may be early in a program/capacity expansion, but returns on the acquisition price are not yet proven.

Are results externally or internally driven?

Both. Raw-material, freight, foreign exchange, vehicle/fuel demand, defense budgets, and program schedules are external. Pricing, mix, customer selection, formulations, plant reliability, sourcing, working capital, acquisitions, and repurchases are internal. The FY2021–2022 margin squeeze and FY2023 inventory release show meaningful environmental sensitivity. The stable four-firm industry roster, persistent R&D spending, and 2026 surcharges show internal capabilities can restore economics.

How stable are revenues?

Consolidated sales increased from $2.36 billion in 2021 to $2.73 billion in 2025, but the path was driven heavily by price rather than volume. Petroleum Additives sales were $2.69 billion in 2023, $2.64 billion in 2024, and $2.53 billion in 2025. Over 2015–2025 petroleum sales grew only about 1.8% annually in nominal dollars. No customer exceeded 10% of consolidated sales in 2023–2025, but management describes a small number of significant multinational-oil-company customers. Revenue is therefore diversified at the reporting threshold but not immune to individual program losses.

What is the product and market outlook?

Lubricant packages should grow slowly in value, with specification complexity and mix offsetting flattish or declining physical demand. Engine oils represent roughly 70% of lubricant-additive volume. Longer drain intervals already offset vehicle-parc growth; EVs add a delayed attrition mechanism because they eliminate engine oil and most fuel-additive use. Hybrids, commercial/off-road fleets, emerging-market parc growth, industrial applications, and e-fluids extend the runway.

A transparent bridge from IHS’s $14 billion 2015 lubricant-additives market using 1%–2% annual underlying growth and the BLS chemical PPI implies a directional 2026 current-dollar market of about $22.5–$25.1 billion. This is an assumption, not a current census. Afton’s $2.16 billion of 2025 lubricant-additive sales implies observable revenue participation near 9%. Fuel additives are a separate, more fragmented market and cannot be sized rigorously from current public evidence.

Specialty Materials addresses ammonium perchlorate for solid rocket propulsion and high-purity hydrazine for spacecraft propulsion. Program qualification, national-security sourcing, purity, safety, and mission history support growth and pricing, while budgets, launch/defense schedules, customer concentration, and single-site operations make quarterly demand less stable.

Primary sources for this section: NewMarket FY2025 Form 10-K, Q2 2026 Form 10-Q, IEA Global EV Outlook 2026, Chemical Week/IHS 2015 market feature, and BLS chemical-manufacturing PPI via FRED, accessed 2026-08-27. The $22.5–$25.1 billion range is an analyst bridge, not a published current market estimate.

Business Quality and Competitive Moat

Is competition becoming more or less intense?

The lubricant-package structure is stable but mildly more expansionary. Afton, Lubrizol, Infineum, and Chevron Oronite have remained the major global suppliers for roughly two decades; historical evidence put the group above 80% in 2006 and around 90% in 2015, although current shares and HHI are not public. Oronite, Infineum, Lubrizol, and component supplier BASF are localizing or adding capacity in Asia and Mexico. These are incumbent projects rather than new full-package entrants. In a 1%–2% growth market, simultaneous additions warrant scrutiny, but a blending plant does not recreate approvals, test data, or customer relationships.

How profitable is NewMarket?

Filing-rebuilt ROIC was approximately 13.4% in 2021, 16.0% in 2022, 23.6% in 2023, 23.6% in 2024, and 16.6% in 2025. ROE was 25.1%, 36.7%, 42.3%, 36.4%, and 25.9%, respectively. Returns are consistently attractive, but the 2025 drop shows that paying for AMPAC/Calca enlarged invested capital faster than reported operating profit. Persistent through-cycle excess return is the financial outcome supporting the moat; the acquisition-adjusted decline is the counter-evidence.

What are the barriers to entry?

The primary barrier is customer captivity reinforced by scale. Lubricant packages are specific combinations of base oil and additives. Changing an approved formulation can require bench, rig, engine, field, API, ACEA, and OEM work; historical regulatory evidence describes months of time and six- to seven-figure costs. Failure can create warranty, equipment, emissions, and brand costs far larger than a small input saving. Incumbents spread laboratories, test hardware, formulation databases, OEM engagement, regulatory support, and global supply over billions of dollars of revenue. Afton alone employs roughly 450 people in R&D/testing and spent $132 million in 2025.

Patents and trade secrets support the system but are not the moat by themselves. There is no network effect. Scale without customer qualification would be replicable; switching costs without a broad technical/supply platform would not create global leadership. The combination has deterred a new major package supplier for two decades.

AMPAC and Calca have narrower but potentially stronger barriers: qualified domestic production, dangerous-material permitting, purity and process control, audits, program history, and mission-critical failure consequences. The barrier is partly regulatory/national-security policy, which can protect incumbents but also makes economics dependent on government procurement.

Can foreign low-cost labor undermine the business?

Not directly. Labor is not the decisive cost or differentiation axis; qualification, data, formulation, process safety, and supply reliability dominate. Chinese and regional suppliers can gain component or domestic share and may eventually accumulate approvals. That is a long-run competitive threat, especially if customers actively sponsor alternatives. For AMPAC and Calca, national-security qualification reduces near-term foreign substitution, although it creates policy concentration.

Does brand matter, and what is the nature of competition?

Afton is a technical business-to-business brand, not a consumer franchise. Reputation matters insofar as it represents performance history, problem-solving, regulatory competence, and reliable global supply. Competition occurs through approved product performance, formulation cost, R&D response to new specifications, technical service, supply assurance, and price. Afton’s independence may make it a neutral partner to oil marketers competing with ExxonMobil/Shell and Chevron, whose parents own Infineum and Oronite, but Afton lacks those rivals’ captive downstream channels.

What are customer switching costs?

They are moderate-to-high in OEM-specific engine and driveline packages, moderate in broader fuel applications, and high in qualified rocket/space chemicals. Switching requires search, validation, production conversion, approvals, and acceptance of supply/warranty risk. Public evidence does not quantify Afton retention, requalification time, dual-source rates, or share stability, so the captivity conclusion remains strongly mechanistic but only partly measured.

Primary sources for this section: NewMarket FY2025 Form 10-K, API 1509, 23rd edition, European Commission Decision 2004/284/EC, and NewMarket FY2006 Form 10-K, accessed 2026-08-27. Filing-rebuilt ROIC inputs come from the FY2022 and FY2025 audited statements.

Financial Condition and Balance Sheet

Are assets understated or missing?

The balance sheet understates U.S. petroleum inventory relative to replacement cost because of LIFO: year-end 2025 carrying value was $91 million below replacement cost. It also does not capitalize internally created formulation knowledge, patents, test data, OEM relationships, or trained personnel. Conversely, acquisitions have capitalized approximately $817 million of Specialty Materials goodwill and intangibles, so the new platform is not hidden; its accounting value depends on forecast growth, attrition, discount rates, and utilization.

The $605 million prepaid pension asset at June 2026 is a genuine overfunded asset, but its economic availability is constrained by plan obligations and regulation. It also generates material non-service pension income based partly on an 8% expected return assumption. Investors should not equate the asset dollar-for-dollar with distributable cash.

What off-balance-sheet or contingent liabilities matter?

Operating leases, environmental remediation, chemical-handling obligations, product/warranty exposure, pension assumptions, purchase commitments, and site-specific interruption risk matter. Filed borrowings exclude lease liabilities. No restatement, material internal-control weakness, or accumulated goodwill impairment was identified. The catastrophic cases are a prolonged outage or safety/environmental event at AMPAC’s Utah site or Calca’s Louisiana site, or a serious Afton product-performance/supply failure.

Is accounting conservative?

The audited statements received an unqualified opinion and controls were effective. Revenue is generally point-in-time; annual rebate true-ups were only $3–$5 million. Stock compensation was approximately $3 million in 2025. Cash conversion over five years is strong.

The material caveats are acquisition and pension accounting. Approximately 93% of AMPAC’s purchase price went to goodwill and intangibles. Calca’s preliminary allocation was still changing in June 2026, and PwC identified its customer-relationship valuation as a critical audit matter. Non-service pension income was about $53 million in 2025—9.5% of pretax income and largely non-cash in the period. Reported operating profit and cumulative cash flow are cleaner than net income alone.

How capital-intensive is the business?

The mature petroleum core has recently reinvested near maintenance: additions to long-lived assets were roughly 0.91x D&A in 2024 and 0.95x in 2025. Consolidated capex was $48–$79 million annually in 2021–2025, only 2%–3% of sales, and cumulative FCF equaled 93% of net income. Specialty expansion changes the near-term profile. H1 2026 capex rose 77%, full-year guidance is $100–$130 million, and the AMPAC line alone may cost up to $100 million.

Primary sources for this section: NewMarket FY2025 Form 10-K, FY2022 Form 10-K, filed 2023-02-15, and Q2 2026 Form 10-Q, accessed 2026-08-27. These filings support capex, pension, LIFO, debt, intangible, cash-flow, and control conclusions.

Capital Allocation and Management

How much free cash flow is generated and how is it used?

From 2021 through 2025, NewMarket generated $1.94 billion of CFO and $1.62 billion of analyst-defined FCF against $1.74 billion of net income. Uses span dividends, repurchases, debt management, internal investment, and acquisitions. End-of-period shares declined 15.8% from December 2020 to June 2026, demonstrating that repurchases more than offset awards. In H1 2026 the company returned $182 million—$56 million of dividends and $126 million of repurchases—while leverage remained modest.

Management’s historical posture is owner-oriented and flexible, but the share price paid matters. Repurchases made at lower historical valuations created obvious per-share value; purchases near the current own-history sales-multiple extreme face a higher hurdle. The same discipline applies to M&A: financing capacity is not the issue; earned returns are.

What significant acquisitions were made?

AMPAC closed on 2024-01-16 for approximately $697 million, funded with cash and revolver borrowings. It contributed $141 million of 2024 revenue and $17.8 million of pretax income, with first-year profit suppressed by inventory step-up. Calca closed on 2025-10-01 for approximately $218 million, also funded with cash/revolver borrowing. Public segment disclosure combines the two. These deals created the Specialty Materials reporting segment and moved NewMarket from a pure petroleum-additives cash engine toward defense/space propulsion chemicals.

The strategic logic is adjacent chemistry, qualification, difficult manufacturing, and mission-critical customer outcomes. The economic proof is incomplete. Investors should demand a post-purchase return bridge including organic revenue, EBIT before/after amortization, working capital, maintenance and growth capex, utilization, and program concentration.

Is the company issuing stock to insiders?

No meaningful dilution problem appears in the financial record. Stock-compensation expense was about $3 million in 2025, and both weighted-average and end-of-period shares have declined substantially. Form 4 activity must be classified by transaction code: awards, withholding, gifts, and family/estate transfers are not equivalent to discretionary open-market sales.

How are management and directors motivated?

The Gottwald family’s large ownership aligns management with long-duration per-share value but also concentrates influence and raises succession/minority-governance questions. The core incentives should be evaluated against operating income, return on capital, cash conversion, leverage, and per-share outcomes rather than revenue expansion. The capital-allocation record is mixed in proof stage: substantial share retirement and low current leverage are positives; roughly $915 million of recent acquisition spending plus expansion capex has yet to demonstrate mature returns.

The 2026 proxy makes the trade-off concrete. Three expressly non-overlapping disclosed buckets—Bruce C. Gottwald, his adult sons in aggregate, and separate family trusts—total approximately 22.7% of shares. CEO Thomas Gottwald’s separately reported 6.0% stake is already included in the adult-sons bucket and must not be added again. His 2025 direct compensation was $3.70 million. Annual incentives begin with adjusted operating profit, while five-year performance stock uses terminal adjusted EPS; neither plan contains ROIC or cumulative FCF. The long horizon and capped award are constructive, but buybacks and debt-funded acquisitions can raise EPS without earning an adequate incremental return.

Governance deserves a discount even without a voting revolt. Six relatives of the CEO and chief administrative officer received approximately $2.65 million of combined 2025 employee compensation, and the company has no formal related-transaction approval standards beyond case-by-case Audit Committee review. The CEO also chairs the board; five of seven directors are independent, but independent-director tenure is long and no CEO succession timetable is public. Shareholders nevertheless approved 2026 say-on-pay with about 97% of votes cast for/against.

The trailing 24-month Form 4 record is quiet. Independent director Ting Xu made the only discretionary open-market purchase—400 shares at $619.21, about $248,000, in February 2026. Chief administrative officer Bruce Hazelgrove made the only open-market sale—311 shares at $642.43 under a Rule 10b5-1 plan. The remaining transactions were awards, withholding, gifts, or trust/estate transfers and should not be characterized as discretionary selling.

Primary sources for this section: NewMarket 2026 Definitive Proxy, FY2025 Form 10-K, Q2 2026 Form 10-Q, AMPAC audited FY2023 financials, Ting Xu Form 4, and Bruce Hazelgrove Form 4, accessed 2026-08-27.

Valuation and Market Data

Is NEU an ADR, partnership, or K-1 issuer?

No. NewMarket Corporation is a Virginia corporation listed on the NYSE under NEU. It is not an ADR, MLP, or K-1 issuer.

What is the dividend policy?

The board declared a $3.00 quarterly dividend in August 2026, or a $12 annualized run rate. At $925.33 this implies a yield near 1.3%. Dividends are meaningful but secondary to repurchases and strategic investment. They are board-authorized rather than contractually guaranteed.

How profitable is the business, and do earnings diverge from cash flow?

FY2025 revenue was $2.73 billion, operating profit $544 million, and operating margin 20.0%. H1 2026 operating margin was 21.7%. Five-year CFO/NI was 111% and FCF/NI 93%, so there is no structural cash-earnings deficit. Annual divergence is large because inventory and payables move: FCF/NI was 19% in 2022 and 136% in 2023. Cumulative metrics are superior.

At the 2026-08-26 close, the stock trades at roughly 19.9x trailing GAAP EPS, 3.15x trailing sales, and a live enterprise value near $9.3 billion after adding current net debt. The sales multiple is near the top of NEU’s own history because current margins are far above the 2021–2022 trough. Valuation therefore rests on margin durability and specialty returns rather than revenue growth alone.

Primary sources for this section: NewMarket Q2 2026 Form 10-Q, direct AZI NEU adjusted-price history, and ROIC.ai NEU, accessed 2026-08-27. Live EV uses $925.33, 9.196 million filed shares, $854.8 million of borrowings, and $93.6 million of cash; own-history valuation percentiles come from the authenticated AZI valuation index.

Risks and Downside

What could cause the stock to decline?

The most plausible drivers are petroleum-margin normalization; evidence that “low-margin pruning” masks share loss; rapid reversal of disruption surcharges; raw-material/freight inflation that again outruns pricing; slower defense/space programs; poor utilization of the new AMPAC line; impairment or weak returns on AMPAC/Calca; accelerated EV/drain-interval attrition; loss of a significant customer or OEM approval; pension-asset/income reversal; family succession or governance concerns; and multiple compression from a current price far above long-term averages.

The stock is empirically event-sensitive. It fell 14.4% on FY2025 results in February 2026 and experienced a five-year maximum drawdown near 33% despite beta below one. A low beta does not protect against idiosyncratic earnings or valuation resets.

Is catastrophic loss possible?

Yes, though unlikely. AMPAC and Calca handle hazardous, mission-critical materials at concentrated sites. A major explosion, environmental release, permitting shutdown, or disqualification could cause loss of life, prolonged outage, remediation, customer disruption, and reputational damage. Afton also faces product-performance, environmental, and supply-chain risks. Insurance and redundancy may reduce financial loss, but public disclosure does not quantify alternative-site qualification or complete replacement time.

What is the chance of total loss?

Low under ordinary stress because Afton is profitable, diversified across products/geographies, cash-generative, and only 1.2x covenant-levered. At unchanged debt, EBITDA would need to fall by roughly two-thirds to approach the normal leverage cap. A true total-loss scenario would require multiple simultaneous failures—catastrophic operational liabilities, severe franchise impairment, and sustained inability to refinance—not a normal additives downturn.

Primary sources for this section: NewMarket FY2025 Form 10-K risk factors, Q2 2026 Form 10-Q, and 2024 credit agreement, accessed 2026-08-27. Drawdown and event returns use the direct AZI adjusted-price history through 2026-08-26.

Recent News and Events

Has the environment changed recently?

Yes. Middle East conflict disrupted logistics/raw materials in 2026, and Afton implemented surcharges that helped Q2 price/mix more than offset shipment pressure. H1 petroleum shipments fell 5.3%, substantially attributed by management to pruning low-margin business, while segment profit rose modestly. This is a useful pricing test but needs several quarters of share/volume evidence.

AMPAC’s added ammonium-perchlorate line is expected to start around year-end 2026 and increase capacity by more than 50%. Commissioning, customer qualification, utilization, and working capital will become more important than construction milestones. Calca contributed to Q2 Specialty Materials growth, but consolidated disclosure prevents a clean organic comparison.

The company returned $182 million in H1 2026 and reported net debt/EBITDA near 1.0x. The board declared another $3.00 quarterly dividend in August. Q2 earnings drove a 10.1% one-day stock increase, reversing part of the 14.4% FY2025-results decline.

Were there accounting-policy or management changes?

No material restatement or internal-control weakness was identified. The most important accounting change is purchase-accounting scope: Calca’s provisional allocation was revised in June 2026, and annual intangible amortization is now approximately $37 million. Pension non-service income remains material. Board and officer changes, insider activity, related-party disclosures, and final Calca accounting should remain on the monitoring list.

Primary sources for this section: NewMarket Q2 2026 earnings Exhibit 99.1, dated 2026-07-29, Q2 2026 Form 10-Q, FY2025 Form 10-K, and August 2026 dividend Form 8-K, accessed 2026-08-27. Price moves use the direct AZI NEU CSV.

APPENDIX B — Source Appendix

A. Primary SEC filings

The SEC filing record is the controlling source for reported financials, segment definitions, risks, acquisitions, debt, pension accounting, and governance. The review covers the complete 60 months from 2021-08-27 through 2026-08-27, including five Forms 10-K, fifteen Forms 10-Q, fifty-two Forms 8-K, five definitive proxies, eighty-two Forms 4, and relevant ownership and administrative filings.

1. NewMarket Corporation, 2025 Form 10-K, filed 2026-02-12. Primary source for the business description; Petroleum Additives and Specialty Materials segment data; competition; customers; raw materials; patents; research and development; properties; risk factors; FY2023–2025 audited statements; AMPAC and Calca purchase accounting; debt; pensions; inventory; and intangible assets. SEC filing, accessed 2026-08-27.
2. NewMarket Corporation, Q2 2026 Form 10-Q, filed 2026-07-30. Primary source for June 2026 balance sheet, H1 cash flow, Q2/H1 segment bridges, Middle East disruption surcharges, volume changes, Calca purchase-accounting update, debt/covenant status, pension balances, repurchases, and AMPAC capacity-project timing. SEC filing, accessed 2026-08-27.
3. NewMarket Corporation, 2024 Form 10-K, filed 2025-02-14. Used to validate AMPAC’s first-year contribution, acquisition funding, the 2024 petroleum-margin peak, and year-over-year risk-language changes. SEC company archive, accessed 2026-08-27.
4. NewMarket Corporation, 2023 Form 10-K, filed 2024-02-15. Used for the raw-material pass-through recovery, pre-AMPAC capital structure, and acquisition announcement context. SEC company archive, accessed 2026-08-27.
5. NewMarket Corporation, 2022 Form 10-K, filed 2023-02-15. Primary source for FY2021–2022 audited comparative financials and the input-cost/working-capital squeeze. SEC filing, accessed 2026-08-27.
6. NewMarket Corporation, 2021 Form 10-K and all fifteen quarterly filings in the corpus. Used to reconstruct the five-year pricing, margin, cash-conversion, working-capital, leverage, and disclosure chronology. SEC company archive, accessed 2026-08-27.
7. NewMarket Corporation, 2026 Definitive Proxy Statement, filed 2026-03-12. Primary source for ownership, board composition, executive compensation, incentives, governance, related-party disclosures, and shareholder voting. SEC filing, accessed 2026-08-27.
8. NewMarket Corporation Forms 8-K and exhibits, 2021-08-27 through 2026-08-27. Used for quarterly earnings releases, dividends, debt amendments, acquisition announcements, director/officer changes, annual-meeting results, and other current events. The relevant SEC accession index and Exhibit 99.1 were checked whenever an 8-K cover incorporated an earnings release by reference. SEC company archive, accessed 2026-08-27.
9. NewMarket Corporation Forms 4, 2024-08-27 through 2026-08-27, plus the wider five-year insider corpus. Raw XML was used to distinguish open-market purchases/sales from awards, withholding, gifts, and other transaction codes, and to inspect any Rule 10b5-1 indicator. SEC company archive, accessed 2026-08-27.
10. 2024 revolving credit agreement, filed as Exhibit 10.1 to the 2024-01-25 Form 8-K. Used for leverage definitions, the 3.75x normal maximum, acquisition step-up, and covenant mechanics. SEC exhibit, accessed 2026-08-27.
11. AMPAC acquisition and historical financials. The 2024-01-22 closing Form 8-K and 2024-02-28 amendment supplied purchase consideration, funding, and acquired FY2023 revenue, operating income, depreciation/amortization, debt, and interest. Closing Form 8-K and AMPAC financial statements, accessed 2026-08-27.
12. Ting Xu and Bruce Hazelgrove Forms 4. Used to distinguish the only discretionary open-market purchase and planned open-market sale in the trailing 24-month corpus. Xu Form 4 and Hazelgrove Form 4, accessed 2026-08-27.

B. Primary company and transcript evidence

1. NewMarket Q2 2026 earnings-call transcript, dated 2026-07-30, retrieved through ROIC.ai. Management reported Q2 net income of $133.8 million, Petroleum Additives sales of $675.6 million and segment operating profit of $149.4 million, Specialty Materials sales of $67.2 million and segment operating profit of $22.3 million, H1 capital returns of $182 million, and covenant net-debt/EBITDA of about 1.0x. The available transcript contains prepared remarks and no analyst Q&A; it therefore provides management framing but limited adversarial diligence. ROIC.ai NEU issuer page, accessed 2026-08-27.
2. Afton Chemical eMobility materials. Used to identify the required properties of hybrid/BEV transmission and thermal-management fluids. These are company marketing claims and were treated as hypotheses unless corroborated by specification or financial evidence. Afton eMobility, accessed 2026-08-27.
3. NewMarket investor-relations and earnings materials. Used as navigation to SEC-filed releases. When a release was filed as an exhibit, the SEC copy controlled. NewMarket, accessed 2026-08-27.

C. Industry, specification, and competitor sources

1. American Petroleum Institute, API 1509, 23rd edition, 2025. Current engine-oil licensing, formulation, test, and interchange framework, including the GF-7 transition. API 1509, accessed 2026-08-27.
2. API Engine Oil Licensing and Certification System and Motor Oil Guide, 2025 guide. Used for current claims, tests, and specification context. API engine oil and API Motor Oil Guide, accessed 2026-08-27.
3. ACEA Oil Sequences, 2023. Used for European engine-oil specification context and the continued increase in formulation complexity. ACEA sequences, accessed 2026-08-27.
4. European Commission Decision 2004/284/EC, 2004. Historical primary evidence on the time and cost of formulation-specific automotive-lubricant approval and base-oil interchange. The figures are dated and were used to establish the mechanism, not as current cost estimates. EUR-Lex, accessed 2026-08-27.
5. Technical Committee of Petroleum Additive Manufacturers in Europe, Lubricant Additives—Use and Benefits, 2016. Industry size, R&D intensity, applications, and value-chain context. ATC publication, accessed 2026-08-27.
6. Evonik Oil Additives investor visit, January 2025. Finished-lubricant volumes, formulation composition, value chain, transport flows, and success factors. Evonik is an interested participant, so its market framing was used directionally. Evonik presentation, accessed 2026-08-27.
7. Chemical Week/IHS lubricant-additives feature, 2015. Historical market size, growth, and four-firm concentration. The date is explicit; a BLS price-index bridge, rather than a false current quote, was used to estimate a current-dollar range. IHS feature hosted by Lubrizol, accessed 2026-08-27.
8. BLS Chemical Manufacturing Producer Price Index via FRED. Used only to bridge the dated 2015 market-size estimate into current dollars. FRED series PCU325325, accessed 2026-08-27.
9. IEA Global EV Outlook 2026. Electric-vehicle new-sales and installed-fleet data used to separate the sales penetration clock from the slower petroleum-fluid stock attrition. IEA executive summary and IEA trends in electric cars, accessed 2026-08-27.
10. Competitor primary sources. Lubrizol’s product/technical pages; Infineum’s 2026-04-30 Stellantis approval and e-mobility materials; Chevron Oronite’s 2024-05-22 Ningbo expansion; Infineum’s 2024-11-18 India production announcement; Lubrizol’s July 2024 India land acquisition; and BASF’s 2025-03-20 Puebla antioxidant expansion were used to test whether Afton’s capabilities and capital cycle are unique. Lubrizol additives, Infineum approval, Chevron Oronite expansion, Infineum India, Lubrizol India, and BASF Puebla, accessed 2026-08-27.
11. EPA final vehicle-GHG action, 2026-02-12. Used only if discussing how U.S. regulatory support for tighter vehicle greenhouse-gas standards changed in 2026; OEM, API, ACEA, and non-U.S. specifications continue independently. EPA release, accessed 2026-08-27.
12. Innospec Q2 2026 earnings release, filed 2026-08-04. Used as a scale cross-check for the independent fuel-additives competitor, not as a lubricant-package market-share estimate. SEC Exhibit 99.1, accessed 2026-08-27.

D. Quantitative sources

1. SEC filing rebuild. Revenue, margins, cash flow, capex, working capital, shares, debt, segment results, acquisition accounting, and return-on-capital calculations were rebuilt from filed statements. Analyst-defined free cash flow equals cash from operations less purchases of property, plant, and equipment. Filing ROIC equals after-tax operating profit divided by average borrowings plus equity less cash; it excludes leases for consistency with company borrowings.
2. ROIC.ai. Used for issuer resolution, cross-checks of filed statements/ratios, the Q2 2026 transcript, and the company-news query. ROIC.ai cash-flow capex and FCF fields were rejected because capex was null; its debt fields use inconsistent lease scopes, and its fixed-assets label does not reproduce filed PP&E. Fiscal-period enterprise values were not used for the current valuation.
3. AZI price and valuation feeds. Direct NEU adjusted-price CSV through 2026-08-26 supplied the event map, total returns, moving averages, and drawdowns. The authenticated valuation index supplied own-history percentiles for P/E, P/B, P/S, and the composite. AZI statement arrays were not used. Own-history percentiles are positioning evidence, not cross-sectional peer rankings. Accessed 2026-08-27.
4. FactorsToday. Stock-info, factor-loading, leaderboard, specific-volatility, and related-stock endpoints supplied empirical factor character. The model’s low R-squared means most NEU variance was idiosyncratic; factor-neighbor names were not treated as operating peers. FactorsToday API, accessed 2026-08-27.

E. Source hierarchy and limitations

The evidence hierarchy was: SEC filings and exhibits; company-filed releases and transcripts; regulator/specification sources; competitor primary materials; quantitative feeds; then dated industry estimates. Material factual claims were reconciled to a filing where available. Management and competitor marketing claims were labeled as hypotheses or corroborative evidence.

Important limitations remain. NewMarket does not disclose current global market share, customer-retention data, dual-source rates, qualification cost/time, Afton e-fluid revenue, regional utilization, Calca standalone profit, or AMPAC/Calca contract coverage. The current lubricant-additives market range is an explicit bridge from a dated IHS estimate, not a contemporary market census. The Q2 transcript lacks Q&A. Same-day stock-move attribution is strongest on earnings dates and probabilistic elsewhere. The public record therefore supports a moat and earnings-quality judgment more strongly than it supports precise share or acquisition-return forecasts.